Growth Metrics

Aterian (ATER) Cost of Revenue (2018 - 2025)

Historic Cost of Revenue for Aterian (ATER) over the last 8 years, with Q3 2025 value amounting to $9.8 million.

  • Aterian's Cost of Revenue fell 2930.56% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.5 million, marking a year-over-year decrease of 2712.38%. This contributed to the annual value of $56.0 million for FY2024, which is 3165.88% down from last year.
  • As of Q3 2025, Aterian's Cost of Revenue stood at $9.8 million, which was down 2930.56% from $12.4 million recorded in Q2 2025.
  • In the past 5 years, Aterian's Cost of Revenue ranged from a high of $39.3 million in Q2 2021 and a low of $9.7 million during Q1 2025
  • In the last 5 years, Aterian's Cost of Revenue had a median value of $20.6 million in 2023 and averaged $22.2 million.
  • As far as peak fluctuations go, Aterian's Cost of Revenue skyrocketed by 6352.9% in 2021, and later tumbled by 4210.32% in 2023.
  • Aterian's Cost of Revenue (Quarter) stood at $30.7 million in 2021, then rose by 6.05% to $32.5 million in 2022, then crashed by 37.84% to $20.2 million in 2023, then tumbled by 32.25% to $13.7 million in 2024, then fell by 28.16% to $9.8 million in 2025.
  • Its last three reported values are $9.8 million in Q3 2025, $12.4 million for Q2 2025, and $9.7 million during Q1 2025.